SAN DIEGO--(BUSINESS WIRE)--June 21, 2006--SkinMedica, Inc., a specialty pharmaceutical company focused on developing, acquiring and commercializing products that improve the appearance of skin and treat dermatologic conditions and diseases, today announced that it has closed a $20.5 million debt facility, consisting of a $13.0 million Term Loan and a $7.5 million Revolving Line of Credit, with Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services, Inc.
